The Oncology Care Model (OCM) has helped practices develop their capacity to use data for continuous quality improvement, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.
The Oncology Care Model (OCM) has helped practices develop their capacity to use data for continuous quality improvement, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.
Transcript:
How has Oncology Care Model (OCM) participation affected practice transformation?
OCM has impacted practice transformation in I think 3 important ways. One is the MEOS payments, or care management payments, associated with the model have underwritten a lot of the investments that practices have wanted to make in improving care delivery. The second way in which OCM has influenced practice transformation is by helping practices develop the capacity to use data for continuous quality improvement, with regard to care delivery that will be important for future participation in alternative payment models. I would say the third reason why OCM has impacted practice transformation is by augmenting the capacity for practices to implement the operational activities that are going to be necessary in the future for alternative payment models. A couple examples of this would be tracking attribution to these models and understanding the stop-loss insurance market, which practices would not have had to do without participating in OCM. That will be critical for them to be capable of going forward.
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More